Importer of Controlled Substances Application: Rhodes Technologies, 21807 [2019-10010]

Download as PDF 21807 Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices transfer of control of the cultural item to the lineal descendants, Indian Tribes, or Native Hawaiian organizations stated in this notice may proceed. DATES: Lineal descendants or representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to claim this cultural item should submit a written request with information in support of the claim to the Pueblo Grande Museum at the address in this notice by June 14, 2019. ADDRESSES: Lindsey Vogel-Teeter, Pueblo Grande Museum, 4619 E Washington Street, Phoenix, AZ 85331, telephone (602) 495–0901, email lindsey.vogel-teeter@phoenix.gov. SUPPLEMENTARY INFORMATION: Notice is here given in accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), 25 U.S.C. 3005, of the intent to repatriate a cultural item under the control of the Pueblo Grande Museum, Phoenix, AZ, that meets the definition of a sacred object under 25 U.S.C. 3001. This notice is published as part of the National Park Service’s administrative responsibilities under NAGPRA, 25 U.S.C. 3003(d)(3). The determinations in this notice are the sole responsibility of the museum, institution, or Federal agency that has control of the Native American cultural item. The National Park Service is not responsible for the determinations in this notice. History and Description of the Cultural Item Around 1983, a Butterfly Dance Tablita (headdress) was donated to the Pueblo Grande Museum by Holley Swan, a patron of the Museum. No additional information is known about the collecting history of this object. During consultation on January 10, 2017, representatives of the Hopi Tribe of Arizona demonstrated the Tribe’s cultural affiliation with this object, and established that the object was needed for use by girls during a traditional Hopi ceremony, the Butterfly dance. jbell on DSK3GLQ082PROD with NOTICES Determinations Made by the Pueblo Grande Museum Officials of the Pueblo Grande Museum have determined that: • Pursuant to 25 U.S.C. 3001(3)(C), the one cultural item described above is a specific ceremonial object needed by traditional Native American religious leaders for the practice of traditional Native American religions by their present-day adherents. • Pursuant to 25 U.S.C. 3001(2), there is a relationship of shared group identity that can be reasonably traced VerDate Sep<11>2014 22:43 May 14, 2019 Jkt 247001 between the sacred object and the Hopi Tribe of Arizona. Additional Requestors and Disposition Lineal descendants or representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to claim this cultural item should submit a written request with information in support of the claim to Lindsey Vogel-Teeter, Pueblo Grande Museum, 4619 E Washington Street, Phoenix, AZ 85331, telephone (602) 495–0901, email lindsey.vogel-teeter@ phoenix.gov, by June 14, 2019. After that date, if no additional claimants have come forward, transfer of control of the sacred object to the Hopi Tribe of Arizona may proceed. The Pueblo Grande Museum is responsible for notifying the Hopi Tribe of Arizona that this notice has been published. Dated: April 25, 2019. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2019–09995 Filed 5–14–19; 8:45 am] BILLING CODE 4312–52–P The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on March 11, 2019, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816 applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Rhodes Technologies ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 14, 2019. Such persons may also file a written request for a hearing on the application on or before June 14, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: PO 00000 Frm 00060 Fmt 4703 Sfmt 9990 Tetrahydrocannabinols .. Methylphenidate ............. Oxycodone ..................... Hydromorphone ............. Hydrocodone .................. Morphine ........................ Opium, raw .................... Oxymorphone ................ Poppy Straw Concentrate. Drug code 7370 1724 9143 9150 9193 9300 9600 9652 9670 Schedule I II II II II II II II II The company plans to import Opium, raw (9600), and Poppy Straw Concentrate (9670) in order to bulk manufacture controlled substances in Active Pharmaceutical Ingredient (API) form. The company distributes the manufactured APIs in bulk to its customers. The company plans to import the other listed controlled substances for internal reference standards use only. The comparisons of foreign reference standards to the company’s domestically manufactured API will allow the company to export domestically manufactured API to foreign markets. Dated: April 27, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–10010 Filed 5–14–19; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\15MYN1.SGM 15MYN1

Agencies

[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Page 21807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10010]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Rhodes 
Technologies

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before June 14, 2019. Such 
persons may also file a written request for a hearing on the 
application on or before June 14, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on March 
11, 2019, Rhodes Technologies, 498 Washington Street, Coventry, Rhode 
Island 02816 applied to be registered as an importer of the following 
basic classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols................         7370  I
Methylphenidate......................         1724  II
Oxycodone............................         9143  II
Hydromorphone........................         9150  II
Hydrocodone..........................         9193  II
Morphine.............................         9300  II
Opium, raw...........................         9600  II
Oxymorphone..........................         9652  II
Poppy Straw Concentrate..............         9670  II
------------------------------------------------------------------------

    The company plans to import Opium, raw (9600), and Poppy Straw 
Concentrate (9670) in order to bulk manufacture controlled substances 
in Active Pharmaceutical Ingredient (API) form. The company distributes 
the manufactured APIs in bulk to its customers.
    The company plans to import the other listed controlled substances 
for internal reference standards use only. The comparisons of foreign 
reference standards to the company's domestically manufactured API will 
allow the company to export domestically manufactured API to foreign 
markets.

    Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10010 Filed 5-14-19; 8:45 am]
 BILLING CODE 4410-09-P